InsiderTrades.com logo

YTEN Insider Trading

Insider Ownership Percentage: 6.10%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00

Yield10 Bioscience Insider Trading History Chart

This chart shows the insider buying and selling history at Yield10 Bioscience by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Yield10 Bioscience Share Price & Price History

Current Price: $0.00
Price Change: +0.30 (1.20%)
As of 04/8/2026 01:00 AM ET

This chart shows the closing price history over time for YTEN up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Yield10 Bioscience Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/19/2023Jack W SchulerMajor ShareholderSell1,500$5.04$7,560.0065,289View SEC Filing Icon  
12/8/2023Jack W SchulerMajor ShareholderSell1,458$5.76$8,398.0866,789View SEC Filing Icon  
10/6/2023Jack W SchulerMajor ShareholderSell1,580$7.20$11,376.0036,373View SEC Filing Icon  
10/4/2023Jack W SchulerMajor ShareholderSell1,724$7.44$12,826.5638,398View SEC Filing Icon  
8/15/2023Jack W SchulerMajor ShareholderBuy31,875$15.60$497,250.0068,248View SEC Filing Icon  
5/5/2023Jack W SchulerMajor ShareholderBuy13,982$71.52$999,992.6440,123View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Yield10 Bioscience (NASDAQ:YTEN)

4.91% of Yield10 Bioscience stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at YTEN by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Yield10 Bioscience Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/10/2023Grand Wealth Management LLC28,282$78K0.0%N/A0.558%Search for SEC Filing on Google Icon
2/3/2023Cannell & Co.258,838$0.43M0.0%+60.5%5.219%Search for SEC Filing on Google Icon
11/7/2022Virtu Financial LLC15,810$47K0.0%N/A0.322%Search for SEC Filing on Google Icon
5/10/2022Cannell & Co.161,338$0.86M0.0%-7.9%3.297%Search for SEC Filing on Google Icon
2/9/2022Cannell & Co.175,213$0.86M0.0%-7.5%3.589%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Yield10 Bioscience logo
Yield10 Bioscience, Inc. operates as an agricultural bioscience company that focuses on commercializing products using the Camelina oilseeds in the United States. Its products include Camelina oil for production of high levels of the omega-3 fatty acids eicosapentanoic acid (EPA) and docosahexanoic acid (DHA); and for use as a low-carbon intensity feedstock oil for biofuels, including biodiesel, renewable diesel (RD), and sustainable aviation fuel (SAF). The company was formerly known as Metabolix, Inc. and changed its name to Yield10 Bioscience, Inc. in January 2017. Yield10 Bioscience, Inc. was incorporated in 1992 and is headquartered in Woburn, Massachusetts.
Read More on Yield10 Bioscience

Today's Range

Now: N/A

50 Day Range

MA: N/A

52 Week Range

Now: N/A

Volume

8 shs

Average Volume

78,164 shs

Market Capitalization

$257 thousand

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.48

Who are the company insiders with the largest holdings of Yield10 Bioscience?

Yield10 Bioscience's top insider investors include:
  1. William P Scully (Major Shareholder)
  2. William P Scully (Major Shareholder)
  3. Jack W Schuler (Major Shareholder)
  4. Matthew Strobeck (Director)
  5. Oliver P Peoples (CEO)
  6. Anthony J Sinskey (Director)
  7. Birchview Capital Gp, Llc (Director)
  8. Charles B Haaser (CAO)
  9. Family Foundation Schuler (Major Shareholder)
  10. Joseph H Shaulson (CEO)
Learn More about top insider investors at Yield10 Bioscience.

Yield10 Bioscience Active Insiders

Charles B Haaser
Charles B Haaser (Age 70)
CAO
Anthony J Sinskey
Anthony J Sinskey (Age 86)
Director